Equities

AFT Pharmaceuticals Ltd

AFT Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NZD)2.65
  • Today's Change0.00 / 0.00%
  • Shares traded21.74k
  • 1 Year change-19.21%
  • Beta0.4881
Data delayed at least 20 minutes, as of Nov 21 2024 22:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of NZD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue195157130
OPERATING EXPENSES
Cost of revenue total1078469
Selling, general and admin. expenses, total554736
Depreciation/amortization1.010.920.26
Unusual expense(income)------
Other operating expenses, total(0.53)0(0.23)
Total operating expense171137110
Operating income242020
Other, net0.010.00(0.18)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes221619
Provision for income taxes6.415.15(1.16)
Net income after taxes161120
Minority interest------
Net income before extra. Items161120
Total extraordinary items------
Net income161120
Inc.avail. to common excl. extra. Items161120
Inc.avail. to common incl. extra. Items161120
EPS RECONCILIATION
Basic/primary weighted average shares105105105
Basic/primary eps excl. extra items0.150.100.19
Basic/primary eps incl. extra items0.150.100.19
Dilution adjustment------
Diluted weighted average shares105105105
Diluted eps excl. extra items0.150.100.19
Diluted eps incl. extra items0.150.100.19
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.020.01--
Gross dividend - common stock1.701.200
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental3.692.872.44
SUPPLEMENTAL INCOME
Depreciation, supplemental1.000.810.83
Total special items------
NORMALISED INCOME
Normalized income before taxes221619
Effect of special items on income taxes------
Income tax excluding impact of special items6.415.15(1.16)
Normalized income after tax161120
Normalized income avail. to common161120
Basic normalized EPS0.150.100.19
Diluted normalized EPS0.150.100.19
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.